Join the 'Growth Hormone Reserve Test' group to help and get support from people like you.
Growth Hormone Reserve Test News
Posted 16 Jun 2015 by Drugs.com
TUESDAY, June 16, 2015 – Short boys are much more likely than short girls to receive growth hormones, a new study finds. Researchers examined the medical records of more than 283,000 children and teens in the United States and found that short boys were up to three times more likely than short girls to receive recombinant human growth hormone treatment. Specifically, males accounted for 74 percent of patients who received the hormone to treat idiopathic short stature – shortness due to an unknown cause. Among patients who received the hormone for any diagnoses, 66 percent were male. The biggest gender differences in treatment occurred around puberty, when less time remains to correct poor growth in children, the researchers noted. The findings were published online June 9 in the journal Scientific Reports. "Growth is an important sign of child health, so growth failure merits equal ... Read more
Related support groups: Humatrope, Pediatric Growth Hormone Deficiency, Genotropin, Nutropin, Saizen, Norditropin, Serostim, Nutropin AQ, Omnitrope, Somatropin, Growth Hormone Reserve Test, Tev-Tropin, Zomacton, Zorbtive, Nutropin Depot, Accretropin, Norditropin FlexPro, Norditropin Nordiflex, Growth Retardation, HumatroPen